Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04338776 · ClinicalTrials.gov registry record · NA

Comparing UroLift Experience Against Rezūm

A NA study of Benign Prostatic Hyperplasia, sponsored by NeoTract.

Active
Registry status
NA
Development phase
120
Enrollment target
10
Study locations

NCT04338776 is a NA study of Benign Prostatic Hyperplasia that is active but no longer recruiting, run by NeoTract. The registered enrollment target is 120 participants, below the 548-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (78% lower). The trial reports 10 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04338776, a NA study of Benign Prostatic Hyperplasia, is active but no longer recruiting, sponsored by NeoTract.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
120 participants
Enrollment target
10
Study locations

Study Summary

C.L.E.A.R. Study is poised to compare the patient experience post procedure, including catheterization needs as well as retreatment and BPH medication rates following treatment with either the UroLift® System or Rezūm™ System through 12 months.

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • DEVICE UroLift
  • DEVICE Rezum

Study Locations (10)

Texas

  • Urology Austin - Austin
  • UT Southwestern Medical Center - Dallas
  • Urology San Antonio - San Antonio

New York

  • NYU Winthrop Urology - Garden City
  • Weil Cornell Medical College, Cornell University - New York

California

  • Tower Urology - Los Angeles

Michigan

  • Comprehensive Urology - Royal Oak

Camberley

  • Frimley Park Hospital - Frimley

Norfolk

  • NORFOLK and Norwich University Hospital - Norwich

Other

  • Cambridge University Hospitals NHS Foundation Trust - Cambridge

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2021-01-22
Est. Completion 2025-12
Phase NA

Sponsor

NeoTract

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04338776

The ClinicalTrials.gov registry entry for NCT04338776 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 548-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (78% lower). The listed sponsor is NeoTract, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which UroLift is the first listed.

NCT04338776 reports 10 study locations spanning 7 distinct geographic areas - top geographies include Texas, New York, California.

Frequently Asked Questions

What is clinical trial NCT04338776 about?

NCT04338776 is a clinical study titled "Comparing UroLift Experience Against Rezūm". C.L.E.A.R. Study is poised to compare the patient experience post procedure, including catheterization needs as well as retreatment and BPH medication rates following treatment with either the UroLift® System or Rezūm™ System through 12 months.

What is the current status of trial NCT04338776?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2021-01-22. Estimated completion is 2025-12.

What conditions does trial NCT04338776 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT04338776?

The interventions under investigation include: UroLift (DEVICE), Rezum (DEVICE).

Who is sponsoring clinical trial NCT04338776?

This trial is sponsored by NeoTract, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04338776 being conducted?

This trial has 10 study locations across California, Michigan, New York, Texas, Camberley. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.